含SARS CoV RNA病毒样颗粒的构建和表达
病毒样颗粒,,SARS;逆转录聚合酶链反应;,RNA,病毒样颗粒;,核糖核酸酶类,含SARSCoVRNA病毒样颗粒的构建和表达,0引言,1材料和方法,2结果,3讨论,【参考文献】
Construction and expression of viruslike particles containing SARS CoV RNALI ZhenYong, JING JianZhou, LIU MingXia, SHAO DaXiao, FENG YanMing, LI ZhiTao, SONG GuoYing, WANG QiuQi, WANG YunLong, QU LingBo, ZHAO YuFen
1Key Laboratory of Chemobiology, School of Chemistry, Zhengzhou University, Zhengzhou 450052, China, 2SinoAmerican Biotechnology Company, Luoyang 471003, China, 3Henan Provincial Research Centre of Biotechnology, Zhengzhou 450056, China
【Abstract】 AIM: To construct and express RNaseresistant viruslike particles containing the RNA fragments of SARS CoV. METHODS: The primers of MS2 assembly protein gene, coat protein gene and the fragment of SARS Cov RNA polymerase gene were synthesized according to their sequences from Genbank data and were used to amplify their cDNAs by RTPCR. These cDNAs were purified with SABCs ResincolumTM system for DNA purification from agarose gel. Expression vector pTrc99a and their cDNA fragments were ligated together with T4 DNA ligase after digestion with restriction enzymes. The prokaryotic expression was obtained by the transformation of the recombinant plasmid constructed above into E.coli JM109. The obtained viruslike particles were purified and tested by quantitative analysis, RTPCR and stable experiment. RESULTS: The RNaseresistant viruslike particles containing the RNA fragments of SARS CoV was successfully constructed and remained stable for 30 days at 37℃. CONCLUSION: The newtype viruslike particles can be conveniently used as positive control of SARS clinical nucleic diagnostic reagents. ......
您现在查看是摘要页,全文长 10744 字符。